Effects of ketamine and esketamine on death, suicidal behaviour, and suicidal ideation in psychiatric disorders: A systematic review and meta-analysis
Martin Plöderl, Ruth Cooper, Tom Walker, Vibha Shah, Mark Horowitz, Constantin Volkmann, Joanna Moncrieff
[Line breaks added]
Background...
After an appeal by Janssen (the pharmaceutical company that manufactures esketamine) in July, NICE reviewed the evidence they submitted again in a technology appraisal guidance (TAG) and recommended against its use for treatment-resistant depression.
The TAG committee’s discussion is an...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.